The Well News on MSNOpinion

340B has gone off the rails

A federal court recently blocked the Trump administration from moving forward with a proposed pilot program that could have ...
If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a ...
The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...
Dartmouth hospital CFO details 340B designation risk and strategic partnership to safeguard federal program participation at Cheshire Medical Center.
The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.
The 340B program was created in 1992 to improve access to care at safety net hospitals and clinics, but hospital leaders have ...
Indiana wants to discontinue Medicaid reimbursement for drugs purchased under a federal program designed to help hospitals ...
There are no requirements that hospitals pass discounts on to any patients, let alone the underserved. | Opinion ...
The past year has seen a great deal of controversy surrounding the 340B Drug Pricing Program, in which drug manufacturers make prescription drugs available to safety net healthcare providers at deeply ...
A new state-by-state analysis released today by HEAL Collaborative provides further insight into how hospitals participating in the 340B program are allocating resources. The study, titled "The 340B ...
The original goal of the 340B drug discount program was to allow qualified providers to “stretch federal resources as far as possible reaching more eligible patients and providing more comprehensive ...
The 340B program presents covered entities with very important financial support to assist with the extension of care to the most vulnerable populations. However, the program is under scrutiny from ...